1. Corporate Officers - G
2. Gergen Mark J

Insider Trading History of Gergen Mark J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Gergen Mark J since 2007. This trader's CIK number is 1373110. At the time of last reporting, Gergen Mark J was the Executive Chairman of Poseida Therapeutics, Inc.. (stock ticker symbol PSTX). Also see all insider trading activities at Poseida Therapeutics, Inc..

Note that in the past Gergen Mark J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Poseida Therapeutics, Inc. (PSTX) by Gergen Mark J

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2024	PSTX	0	$0	60,000	$561,960	60,000	$166,860

Yearly summary of insider trading at Amylin Pharmaceuticals Inc (AMLN) by Gergen Mark J

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2012	AMLN	0	$0	9,364	$159,616	0	$0
2007	AMLN	0	$0	8,500	$377,180	8,500	$142,800

Yearly summary of insider trading at Mirati Therapeutics, Inc. (MRTX) by Gergen Mark J

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	MRTX	0	$0	10,000	$259,210	15,000	$127,500

Insider trading activities at 3 companies by Gergen Mark J:

1. Poseida Therapeutics, Inc. (PSTX)

2. Amylin Pharmaceuticals Inc (AMLN)

3. Mirati Therapeutics, Inc. (MRTX)

Table 1. Insider trading of Poseida Therapeutics, Inc. (PSTX) by Gergen Mark J

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2024-12-10	PSTX	Option Ex	30,000	2.78	83,430
2024-12-10	PSTX	Sale	30,000	9.46	283,860
2024-11-26	PSTX	Option Ex	30,000	2.78	83,430
2024-11-26	PSTX	Sale	30,000	9.27	278,100

Table 2. Insider trading of Amylin Pharmaceuticals Inc (AMLN) by Gergen Mark J

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2012-03-01	AMLN	Sale	1,846	17.11	31,585
2012-02-23	AMLN	Sale	7,518	17.03	128,031
2007-11-01	AMLN	Sale	500	44.00	22,000
2007-11-01	AMLN	Option Ex	500	16.80	8,400
2007-10-03	AMLN	Option Ex	500	16.80	8,400
2007-10-03	AMLN	Sale	500	50.00	25,000
2007-10-01	AMLN	Option Ex	500	16.80	8,400
2007-10-01	AMLN	Sale	500	49.83	24,915
2007-09-04	AMLN	Sale	1,000	49.50	49,500
2007-09-04	AMLN	Option Ex	1,000	16.80	16,800
2007-08-07	AMLN	Option Ex	500	16.80	8,400
2007-08-07	AMLN	Sale	500	50.00	25,000
2007-08-01	AMLN	Sale	500	46.50	23,250
2007-08-01	AMLN	Option Ex	500	16.80	8,400
2007-07-24	AMLN	Option Ex	500	16.80	8,400
2007-07-24	AMLN	Sale	500	45.00	22,500
2007-07-02	AMLN	Option Ex	500	16.80	8,400
2007-07-02	AMLN	Sale	500	41.20	20,600
2007-06-01	AMLN	Sale	1,000	46.16	46,160
2007-06-01	AMLN	Option Ex	1,000	16.80	16,800
2007-05-21	AMLN	Option Ex	500	16.80	8,400
2007-05-21	AMLN	Sale	500	45.00	22,500
2007-05-01	AMLN	Sale	500	41.25	20,625
2007-05-01	AMLN	Option Ex	500	16.80	8,400
2007-04-02	AMLN	Sale	500	37.47	18,735
2007-04-02	AMLN	Option Ex	500	16.80	8,400
2007-03-01	AMLN	Option Ex	500	16.80	8,400
2007-03-01	AMLN	Sale	500	37.75	18,875
2007-02-01	AMLN	Option Ex	500	16.80	8,400
2007-02-01	AMLN	Sale	500	38.75	19,375
2007-01-03	AMLN	Option Ex	500	16.80	8,400
2007-01-03	AMLN	Sale	500	36.29	18,145

Table 3. Insider trading of Mirati Therapeutics, Inc. (MRTX) by Gergen Mark J

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-01-15	MRTX	Option Ex	15,000	8.50	127,500
2016-01-15	MRTX	Sale	10,000	25.92	259,210

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gergen Mark J (Executive Chairman of Poseida Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month